Chronic Incomplete Cervical Spinal Cord Injury (SCI)
0
Pipeline Programs
2
Companies
1
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Mission TherapeuticsUK - Cambridge
1 programTranscutaneous Auricular Vagus Nerve StimulationN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2025
2026
2027
Mission TherapeuticsTranscutaneous Auricular Vagus Nerve Stimulation
Clinical Trials (1)
Total enrollment: 12 patients across 1 trials
Safety and Feasibility of Paired Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) With Upper Limb Rehabilitation in Incomplete Spinal Cord Injury
Start: Aug 2025Est. completion: Dec 202712 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 12 patients
2 companies competing in this space